Diagnostic Criteria for Polycystic Ovary Syndrome

    May 2017
    Francesco Orio, Giovanna Muscogiuri
    Image of study
    TLDR The conclusion is that a more comprehensive and precise approach is needed for diagnosing PCOS to address its broader health risks.
    In 2017, Francesco Orio and Giovanna Muscogiuri reviewed the diagnostic criteria for Polycystic Ovary Syndrome (PCOS), highlighting the use of three main sets of criteria: the NIH, Rotterdam, and AE-PCOS Society criteria. They pointed out the confusion caused by the broadening of diagnostic criteria, which has led to the inclusion of multiple PCOS phenotypes in studies without proper stratification. The document also emphasized the need for a more comprehensive approach to diagnosing PCOS, considering its long-term health risks beyond fertility and cosmetic concerns. The Rotterdam criteria, which have broadened the definition of PCOS, are recommended for diagnosis. The authors called for the exclusion of other disorders in the diagnostic process, the use of new biomarkers, more objective methods for assessing hirsutism, and a clear differentiation between PCOS and PCOM. They suggested using follicle number per ovary (≥25) or ovarian volume for PCOM diagnosis and stressed the importance of further research to refine diagnostic criteria and prevent associated metabolic and cardiovascular diseases.
    Discuss this study in the Community →

    Research cited in this study

    5 / 5 results

    Related Community Posts Join

    6 / 12 results

      community How does hair loss and recovery work?

      in Chat  12 upvotes 2 months ago
      Hair loss varies due to genetic sensitivity to DHT and other factors. Treatments discussed include finasteride, minoxidil, RU58841, and microneedling.

      community C’est terrible - at my wits end

      in Female  443 upvotes 1 year ago
      A 29-year-old woman is experiencing gradual hair thinning since age 15, suspects Androgenic Alopecia, and has tried 5% minoxidil with little success. She has purchased various hair loss treatments including minoxidil, dutasteride, finasteride, and spironolactone, but is cautious about starting them due to potential interactions with her ADHD medication.

      community Female, 30, PCOS diagnosis, MPB Norwood 2. Endo refuses to give anything other than Spironolactone. Feel like I’m at my wit’s end here.

      in Female  56 upvotes 1 year ago
      A 30-year-old female with PCOS and male pattern baldness is frustrated with her endocrinologist's recommendation of only Spironolactone and minoxidil, feeling that dutasteride, finasteride, and progesterone would be more effective. Other users suggest various online sources for treatments, warn against self-medicating due to potential risks, and recommend seeking a specialized endocrinologist or considering additional treatments like Inositol, Berberine, and dermaneedling.

      community Why balding gets worse in every generation?

      in Chat  81 upvotes 5 months ago
      Balding seems to worsen with each generation, possibly due to stress, diet, and environmental factors. The user started treatments like Minoxidil and finasteride.

    Related Research

    2 / 2 results